InvestorsHub Logo
Post# of 4967179
Next 10
Followers 39
Posts 7286
Boards Moderated 0
Alias Born 10/17/2013

Re: None

Monday, 12/18/2023 9:54:11 AM

Monday, December 18, 2023 9:54:11 AM

Post# of 4967179
QUINCE THERAPEUTICS INC QNCX 1,23 + 4,24%

GENEXTRA S.P.A. REPORTS 5.89% PASSIVE STAKE IN QUINCE THERAPEUTICS

Total Cash (mrq) 83.22M
Total Cash Per Share (mrq) 1.94
Total Debt (mrq) 61k
Book Value Per Share (mrq) 2.29
Shares Outstanding 42.87M
Float 31.07M
Shares Short (prior month Oct 30, 2023) 4 2.16M

We see more and more big shareholders, I think we will see 1.50 – 1.75 this week.

Well-capitalized into 2026 with ability to fully fund lead asset EryDex expected through Phase 3 trial under special protocol assessment (SPA) and to NDA submission

https://quincetx.com/pipeline/

time for a strong rebound
Dec 01, 2023 0.9100 1.0500 0.9100 1.0300 1.0300 1,362,700
Oct 31, 2023 0.9500 1.0000 0.8400 0.8900 0.8900 1,624,600
Sep 30, 2023 1.0770 1.2100 0.9300 0.9710 0.9710 1,406,800
Aug 31, 2023 1.3400 1.3600 1.0600 1.1200 1.1200 2,505,300
Jul 31, 2023 1.2100 1.3400 1.1700 1.3100 1.3100 3,672,400
Jun 30, 2023 1.4900 1.7000 1.0800 1.2000 1.2000 13,124,000
May 31, 2023 1.4900 1.6600 1.3500 1.5050 1.5050 1,769,200
Apr 30, 2023 1.5300 1.7400 1.3800 1.5000 1.5000 2,458,500
Mar 31, 2023 1.6100 1.9300 1.4300 1.5300 1.5300 6,290,800
Mar 01, 2023 0.9300 1.5800 0.7900 1.5600 1.5600 62,561,600
Jul 31, 2021 57.1100 121.9800 55.3000 96.3000 96.3000 8,573,500

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.